News & Updates
Filter by Specialty:
Budesonide falls short of improving hyposmia related to COVID-19
Local intranasal treatment with budesonide does not appear to be effective for persistent hyposmia in patients with nonsevere COVID-19, according to a study.
Budesonide falls short of improving hyposmia related to COVID-19
21 Sep 2023
Zuranolone safe, effective for postpartum depression
Use of zuranolone significantly improves depressive symptoms, with no serious side effects, in women with severe postpartum depression (PPD), a common perinatal complication with adverse maternal and infant outcomes, results of a phase III trial have shown.
Zuranolone safe, effective for postpartum depression
20 Sep 2023
NSAIDs up VTE risk in women using hormonal contraception
Treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) appears to increase the risk of venous thromboembolism (VTE) in women using hormonal contraception, reveals a study.
NSAIDs up VTE risk in women using hormonal contraception
20 Sep 2023
Colorectal cancer screening can wait until age 50
Colorectal cancer screening should wait until age 50 for average-risk, asymptomatic adults, says the American College of Physicians (ACP) in its updated guidance. However, this stands in contrast to screening recommendations by the American Cancer Society (ACS) and the US Preventive Services Task Force (USPSTF) to start at age 45.
Colorectal cancer screening can wait until age 50
20 Sep 2023
Extended anticoagulation benefits cancer patients with distal DVT
In cancer patients with isolated distal deep vein thrombosis (IDDVT), a 12-month anticoagulation regimen with the oral factor Xa inhibitor edoxaban fared better than a 3-month regimen, findings from the ONCO DVT study have shown.
